Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 6 studies | 30% ± 18% | |
oligodendrocyte | 6 studies | 26% ± 11% | |
macrophage | 6 studies | 28% ± 7% | |
microglial cell | 5 studies | 22% ± 5% | |
oligodendrocyte precursor cell | 5 studies | 26% ± 6% | |
monocyte | 5 studies | 24% ± 4% | |
dendritic cell | 4 studies | 19% ± 1% | |
endothelial cell | 3 studies | 19% ± 4% | |
epithelial cell | 3 studies | 22% ± 3% | |
GABAergic neuron | 3 studies | 33% ± 8% | |
glutamatergic neuron | 3 studies | 38% ± 4% | |
alveolar macrophage | 3 studies | 23% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 33% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 263.06 | 1444 / 1445 | 100% | 12.14 | 183 / 183 |
breast | 100% | 330.17 | 459 / 459 | 100% | 11.90 | 1117 / 1118 |
lung | 100% | 292.30 | 576 / 578 | 100% | 11.93 | 1155 / 1155 |
uterus | 100% | 216.84 | 170 / 170 | 99% | 13.88 | 456 / 459 |
brain | 99% | 214.43 | 2624 / 2642 | 100% | 10.57 | 705 / 705 |
bladder | 100% | 264.86 | 21 / 21 | 99% | 10.76 | 498 / 504 |
thymus | 100% | 220.89 | 653 / 653 | 99% | 8.88 | 597 / 605 |
kidney | 100% | 287.91 | 89 / 89 | 98% | 11.36 | 885 / 901 |
prostate | 100% | 210.88 | 245 / 245 | 98% | 5.92 | 493 / 502 |
stomach | 99% | 195.58 | 356 / 359 | 99% | 11.38 | 283 / 286 |
intestine | 100% | 286.01 | 966 / 966 | 98% | 12.34 | 517 / 527 |
ovary | 98% | 153.95 | 177 / 180 | 100% | 7.50 | 429 / 430 |
skin | 100% | 339.34 | 1802 / 1809 | 93% | 10.40 | 440 / 472 |
adrenal gland | 100% | 338.05 | 257 / 258 | 90% | 5.67 | 206 / 230 |
pancreas | 89% | 106.36 | 292 / 328 | 99% | 16.12 | 177 / 178 |
liver | 92% | 123.29 | 209 / 226 | 94% | 6.26 | 383 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.06 | 29 / 29 |
spleen | 100% | 382.12 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 14.46 | 45 / 45 |
adipose | 100% | 332.10 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 420.07 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 437.37 | 825 / 861 | 0% | 0 | 0 / 0 |
muscle | 90% | 131.67 | 719 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 88% | 440.10 | 820 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 66% | 3.81 | 53 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051103 | Biological process | DNA ligation involved in DNA repair |
GO_0006303 | Biological process | double-strand break repair via nonhomologous end joining |
GO_0010165 | Biological process | response to X-ray |
GO_0051351 | Biological process | positive regulation of ligase activity |
GO_0006302 | Biological process | double-strand break repair |
GO_0033152 | Biological process | immunoglobulin V(D)J recombination |
GO_1990166 | Biological process | protein localization to site of double-strand break |
GO_0071285 | Biological process | cellular response to lithium ion |
GO_0032807 | Cellular component | DNA ligase IV complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005958 | Cellular component | DNA-dependent protein kinase-DNA ligase 4 complex |
GO_0005829 | Cellular component | cytosol |
GO_0000793 | Cellular component | condensed chromosome |
GO_0035861 | Cellular component | site of double-strand break |
GO_0070419 | Cellular component | nonhomologous end joining complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0016874 | Molecular function | ligase activity |
GO_0070975 | Molecular function | FHA domain binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | XRCC4 |
Protein name | DNA repair protein XRCC4 (hXRCC4) (X-ray repair cross-complementing protein 4) [Cleaved into: Protein XRCC4, C-terminus (XRCC4/C)] |
Synonyms | |
Description | FUNCTION: [DNA repair protein XRCC4]: DNA non-homologous end joining (NHEJ) core factor, required for double-strand break repair and V(D)J recombination . Acts as a scaffold protein that regulates recruitment of other proteins to DNA double-strand breaks (DSBs) . Associates with NHEJ1/XLF to form alternating helical filaments that bridge DNA and act like a bandage, holding together the broken DNA until it is repaired . The XRCC4-NHEJ1/XLF subcomplex binds to the DNA fragments of a DSB in a highly diffusive manner and robustly bridges two independent DNA molecules, holding the broken DNA fragments in close proximity to one other . The mobility of the bridges ensures that the ends remain accessible for further processing by other repair factors . Plays a key role in the NHEJ ligation step of the broken DNA during DSB repair via direct interaction with DNA ligase IV (LIG4): the LIG4-XRCC4 subcomplex reseals the DNA breaks after the gap filling is completed . XRCC4 stabilizes LIG4, regulates its subcellular localization and enhances LIG4's joining activity . Binding of the LIG4-XRCC4 subcomplex to DNA ends is dependent on the assembly of the DNA-dependent protein kinase complex DNA-PK to these DNA ends . Promotes displacement of PNKP from processed strand break termini . .; FUNCTION: [Protein XRCC4, C-terminus]: Acts as an activator of the phospholipid scramblase activity of XKR4 . This form, which is generated upon caspase-3 (CASP3) cleavage, translocates into the cytoplasm and interacts with XKR4, thereby promoting phosphatidylserine scramblase activity of XKR4 and leading to phosphatidylserine exposure on apoptotic cell surface . . |
Accessions | ENST00000282268.7 [Q13426-2] ENST00000396027.9 [Q13426-2] ENST00000511817.1 [Q13426-1] ENST00000338635.10 [Q13426-1] Q13426 |